Neurosense Therapeutics Eulerpool naujienos

Neurosense Therapeutics Eulerpool News

Neurosense Therapeutics akcijų naujienos

Neurosense Therapeutics stebi daugybė žurnalistų ir investuotojų visame pasaulyje. Naujausias Neurosense Therapeutics naujienas mes pateikiame čia.

• rugpjūčio 16 d. ·

  TipRanks
  NeuroSense Therapeutics Announces Share Issuance
• rugpjūčio 7 d. ·

  Yahoo
  NeuroSense Therapeutics Announces Private Placement with Senior Management Participation at Premium to Market Price
• rugpjūčio 7 d. ·

  TipRanks
  NeuroSense Therapeutics Announces Strategic Securities Sale
• rugpjūčio 1 d. ·

  Yahoo
  NeuroSense Therapeutics Announces Positive Biomarker Data from ALS Phase 2b Clinical Trial
• rugpjūčio 1 d. ·

  TipRanks
  NeuroSense’s ALS Drug Shows Promise in Trial
• rugpjūčio 1 d. ·

  Thefly.com
  NeuroSense's PrimeC shows positive biomarker data from ALS Phase 2b trial
• liepos 9 d. ·

  Yahoo
  NeuroSense's PARADIGM ALS Clinical Trial Demonstrates Up to 73% Improved Complication-Free Survival Following Statistically Significant Slowing of Disease Progression
• liepos 1 d. ·

  Yahoo
  NeuroSense Demonstrates Statistically Significant Efficacy and Survival Benefits in People Living with ALS: The Promising Results from the 12-Month PARADIGM Study Highlight PrimeC's Potential as a Disease Modifying Drug
• birželio 27 d. ·

  TipRanks
  NeuroSense Extends Warrant Termination, Revises Terms
• birželio 24 d. ·

  Yahoo
  NeuroSense Management Provides Corporate Update and First Quarter 2024 Financial Results